Home › Funds › SABBY MANAGEMENT, LLC › REVB
SABBY MANAGEMENT, LLC position in REVB
REVELATION BIOSCIENCES INC · Health Care
SABBY MANAGEMENT, LLC reported holding 126,915 shares of REVB (REVELATION BIOSCIENCES INC) in its Q3 2026 13F filing — a position valued at US$104K, representing 2.30% of its reported portfolio and ranking #14 among its reported holdings. SABBY MANAGEMENT, LLC has disclosed REVB holdings in 9 of the last 13 reported quarters, going back to Q3 2023.
Last updated: 2026-11-13 · Source: SEC EDGAR Form 13F-HR
How SABBY MANAGEMENT, LLC's REVB position evolved
SABBY MANAGEMENT, LLC first disclosed a stake in REVB in Q3 2023 at 403,233 shares (US$278.0M). Across 9 filings, SABBY MANAGEMENT, LLC increased the stake 3 time(s), trimmed it 2 time(s) and left it unchanged 1 time(s). The most recent filing (Q3 2026) shows 126,915 shares valued at US$104K — a reduction of -83,667 shares quarter over quarter.. Notable position changes include a 215% increase in Q3 2025 (shares fell 44% over the following quarter), a 193% increase in Q4 2025 (shares fell 63% over the following quarter), a 112% increase in Q2 2026 (shares fell 89% over the following quarter).
Quarter by quarter
| Quarter | Shares | Value | Change |
|---|---|---|---|
| Q3 2023 | 403.23K | $277.99M | New |
| Q4 2023 | 403.23K | $201.90M | Hold |
| Q3 2024 | 42.23K | $35.97K | New |
| Q2 2025 | 65.79K | $49.34K | New |
| Q3 2025 | 207.05K | $294.01K | Add |
| Q4 2025 | 605.70K | $484.44K | Add |
| Q1 2026 | 99.43K | $119.32K | Reduce |
| Q2 2026 | 210.58K | $216.90K | Add |
| Q3 2026 | 126.92K | $103.69K | Reduce |
Dots on the line are colored by change type; missing quarters mean no position was reported.
About REVB and 13F data
REVB (REVELATION BIOSCIENCES INC) is a Health Care company. 13 other funds we track also report a position in REVB. Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.
More on SABBY MANAGEMENT, LLC
FAQ
How long has SABBY MANAGEMENT, LLC held REVB?
SABBY MANAGEMENT, LLC has disclosed REVB holdings in 9 of the last 13 reported quarters, going back to Q3 2023.
What is SABBY MANAGEMENT, LLC's current position in REVB?
As of Q3 2026, SABBY MANAGEMENT, LLC holds 126.92K shares of REVB (REVELATION BIOSCIENCES INC), valued at $103.69K, representing 2.30% of its reported portfolio and ranking #14.
Has SABBY MANAGEMENT, LLC been buying or selling REVB?
In the latest 13F filing (Q3 2026), SABBY MANAGEMENT, LLC reduced its position in REVB.
Where does this data come from?
All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.